MISSION

The main task of the European Research Initiative on Anaplastic lymphoma kinase (ALK)-related malignancies (ERIA) is to strengthen cooperation and partnership of research groups focused on the role of ALK in cancer in order to accelerate scientific progress. With this aim in mind we anticipate that more efficacious and less toxic therapeutic strategies will be developed in the future through intense cooperation of involved partners.

We are grateful to the British Association for Cancer Research (BACR) and Leukaemia and Lymphoma Research for their generous support.